Related Experiment Videos

Late estimation of myocardial infarct size by total creatine kinase nomogram

Insights

Enzymatic estimation of myocardial infarct size is possible late after acute myocardial infarction (AMI). A nomogram using lactate dehydrogenase isoenzyme (LDH1) effectively estimates creatine kinase (CK) release for infarct size assessment.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Estimating myocardial infarct size late after acute myocardial infarction (AMI) is challenging due to limited early enzymatic data.
  • Traditional methods using serum creatine kinase (CK) are less effective beyond 48 hours post-AMI.

Purpose of the Study:

  • To investigate the feasibility of enzymatic estimation of myocardial infarct size in patients presenting days after AMI.
  • To develop and validate a reliable method for late-stage infarct size assessment.

Main Methods:

  • Serial serum enzyme determinations (CK and LDH isoenzymes) were performed in patients following AMI.
  • Correlations between cumulative CK release and lactate dehydrogenase isoenzyme 1 (LDH1) activities were analyzed.
  • A nomogram was developed using serum LDH1 levels (days 2-6) to estimate cumulative total CK release.

Main Results:

  • Significant correlations (r=0.863-0.870) were found between cumulative CK release and serum LDH1 activities from day 2 to day 6 post-AMI.
  • The developed nomogram demonstrated high reliability in estimating cumulative total CK release (r=0.923-0.946).
  • The nomogram requires minimal blood samples for accurate late-stage infarct size estimation.

Conclusions:

  • Enzymatic estimation of myocardial infarct size is feasible using serum LDH1 levels between days 2 and 6 post-AMI.
  • The developed CK nomogram provides a reliable and practical tool for late infarct size assessment.
  • This method aids in managing patients admitted several days after the onset of AMI.

Related Concept Videos